*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Oritavancin is a <strong>lipoglycopeptide antibiotic</strong> developed for treating acute bacterial skin infections. Synthesized via advanced fermentation and semi-synthesis, its molecular formula is C<sub>62</sub>H<sub>78</sub>ClN<sub>9</sub>O<sub>24</sub> (CAS: 150676-56-3).</p>
<h3>Application</h3>
<ul>
<li><strong>Infectious Disease:</strong> Treatment of complicated skin and soft tissue infections caused by Gram-positive bacteria.</li>
<li><strong>Hospital Pharmacy:</strong> Single-dose IV therapy for patients with methicillin-resistant Staphylococcus aureus (MRSA).</li>
<li><strong>Research:</strong> Study of novel glycopeptide mechanisms against resistant strains.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in patients with known hypersensitivity. Store lyophilized powder at controlled room temperature below 25°C. Protect from light and moisture to maintain stability.</p>